首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
ISOLATION OF A SUBPOPULATION OF ADHERENT PERITONEAL CELLS WITH ANTI-TUMOUR ACTIVITY
被引:55
|
作者
:
NATHAN, CF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
NATHAN, CF
[
1
]
HILL, VM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
HILL, VM
[
1
]
TERRY, WD
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
TERRY, WD
[
1
]
机构
:
[1]
NCI,IMMUNOL BRANCH,BETHESDA,MD 20014
来源
:
NATURE
|
1976年
/ 260卷
/ 5547期
关键词
:
D O I
:
10.1038/260146a0
中图分类号
:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号
:
07 ;
0710 ;
09 ;
摘要
:
引用
收藏
页码:146 / 148
页数:3
相关论文
共 50 条
[1]
Anti-tumour activity of bisphosphonates in human myeloma cells
Shipman, CM
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Shipman, CM
Rogers, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Rogers, MJ
Apperley, JF
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Apperley, JF
Russell, RGG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Russell, RGG
Croucher, PI
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB9 2ZD, Scotland
Croucher, PI
LEUKEMIA & LYMPHOMA,
1998,
32
(1-2)
: 129
-
138
[2]
The anti-tumour activity of bisphosphonates
Neville-Webbe, HL
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Neville-Webbe, HL
Holen, I
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Holen, I
Coleman, RE
论文数:
0
引用数:
0
h-index:
0
机构:
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Ctr Canc Res, Div Genomic Med, Sheffield S10 2SJ, S Yorkshire, England
Coleman, RE
CANCER TREATMENT REVIEWS,
2002,
28
(06)
: 305
-
319
[3]
Anti-tumour activity of zoledronic acid
Clézardin, P
论文数:
0
引用数:
0
h-index:
0
机构:
RTH Laennec, INSERM, U664, Fac Med, F-69372 Lyon 08, France
RTH Laennec, INSERM, U664, Fac Med, F-69372 Lyon 08, France
Clézardin, P
CANCER TREATMENT REVIEWS,
2005,
31
: S1
-
S8
[4]
Making macrophages with anti-tumour activity
Crunkhorn, Sarah
论文数:
0
引用数:
0
h-index:
0
Crunkhorn, Sarah
NATURE REVIEWS DRUG DISCOVERY,
2024,
23
(04)
: 253
-
253
[5]
STUDIES ON ANTI-TUMOUR ACTIVITY OF JAWAHARENE
RANADIVE, KJ
论文数:
0
引用数:
0
h-index:
0
RANADIVE, KJ
GOTHOSKAR, SV
论文数:
0
引用数:
0
h-index:
0
GOTHOSKAR, SV
TASKAR, SP
论文数:
0
引用数:
0
h-index:
0
TASKAR, SP
BAPAT, CV
论文数:
0
引用数:
0
h-index:
0
BAPAT, CV
COUTINHO, WG
论文数:
0
引用数:
0
h-index:
0
COUTINHO, WG
INDIAN JOURNAL OF MEDICAL RESEARCH,
1966,
54
(03)
: 229
-
+
[6]
The role of immunomodulation on anti-tumour activity of hexadecylphosphocholine
Safa, O
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV BRADFORD,DEPT BIOMED SCI,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
Safa, O
Parkin, SM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV BRADFORD,DEPT BIOMED SCI,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
Parkin, SM
Bibby, MC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV BRADFORD,DEPT BIOMED SCI,BRADFORD BD7 1DP,W YORKSHIRE,ENGLAND
Bibby, MC
EUROPEAN JOURNAL OF CANCER,
1997,
33
: 65
-
65
[7]
ANTI-TUMOUR ACTIVITY OF 5-MERCAPTOURACIL
BARDOS, TJ
论文数:
0
引用数:
0
h-index:
0
BARDOS, TJ
SEGALOFF, A
论文数:
0
引用数:
0
h-index:
0
SEGALOFF, A
AMBRUS, JL
论文数:
0
引用数:
0
h-index:
0
AMBRUS, JL
NATURE,
1959,
183
(4661)
: 612
-
613
[8]
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
Albertsson, PA
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Albertsson, PA
Basse, PH
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Basse, PH
Hokland, M
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Hokland, M
Goldfarb, RH
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Goldfarb, RH
Nagelkerke, JF
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Nagelkerke, JF
Nannmark, U
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Nannmark, U
Kuppen, PJK
论文数:
0
引用数:
0
h-index:
0
机构:
Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden
Kuppen, PJK
TRENDS IN IMMUNOLOGY,
2003,
24
(11)
: 603
-
609
[9]
Information technology Model for anti-tumour activity
O'Driscoll, Cath
论文数:
0
引用数:
0
h-index:
0
O'Driscoll, Cath
CHEMISTRY & INDUSTRY,
2015,
79
(08)
: 12
-
12
[10]
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
N Ioannou
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
N Ioannou
A G Dalgleish
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
A G Dalgleish
A M Seddon
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
A M Seddon
D Mackintosh
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
D Mackintosh
U Guertler
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
U Guertler
F Solca
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
F Solca
H Modjtahedi
论文数:
0
引用数:
0
h-index:
0
机构:
School of Life Sciences,Department of Cellular and Molecular Medicine
H Modjtahedi
British Journal of Cancer,
2011,
105
: 1554
-
1562
←
1
2
3
4
5
→